Disagree Index. ACW went from 2.5 cents to 14 cents on preclinical data in 2015. It was just hypothesis and great science back then...now it is being proved up. The recent data will be hitting the inboxes of big pharma who have spent Billions and Billions and failed in this area. It’s Novel approach is where the greatest value is and on the latest conference call the Bell Potter biotech analyst congratulated Bill on a world first...Analysts rarely compliment let alone congratulate???
Ann: Cognitive improvement demonstrated with Xanamem, page-509
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.3¢ |
Change
-0.001(4.17%) |
Mkt cap ! $70.90M | |||
| Open | High | Low | Value | Volume |
| 2.5¢ | 2.5¢ | 2.3¢ | $29.76K | 1.224M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 3353309 | 2.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 300000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| ACW (ASX) Chart |